C lostridium difficile is classified as one of the top three urgent antibiotic resistance threats by the Centers for Disease Control and Prevention. The pathology of CDI is primarily mediated by two homologous exotoxins, TcdA and TcdB, which target and disrupt the colonic epithelium, leading to diarrhea and colitis [1] [2] [3] [4] [5] . While the relative roles of these two toxins in the pathogenesis of CDI are not completely understood, recent studies have shown that TcdB is more virulent than TcdA and more important for inducing the host inflammatory and innate immune responses [5] [6] [7] [8] . Notably, a TcdB-neutralizing antibody (bezlotoxumab) was recently approved by the US Food and Drug Administration as a prevention against recurrent infection 9 . However, more effective therapies for CDI are desperately needed.
C lostridium difficile is classified as one of the top three urgent antibiotic resistance threats by the Centers for Disease Control and Prevention. The pathology of CDI is primarily mediated by two homologous exotoxins, TcdA and TcdB, which target and disrupt the colonic epithelium, leading to diarrhea and colitis [1] [2] [3] [4] [5] . While the relative roles of these two toxins in the pathogenesis of CDI are not completely understood, recent studies have shown that TcdB is more virulent than TcdA and more important for inducing the host inflammatory and innate immune responses [5] [6] [7] [8] . Notably, a TcdB-neutralizing antibody (bezlotoxumab) was recently approved by the US Food and Drug Administration as a prevention against recurrent infection 9 . However, more effective therapies for CDI are desperately needed.
TcdA (~308 kDa) and TcdB (~270 kDa) contain four functional domains: an N-terminal glucosyltransferase domain (GTD), a cysteine protease domain (CPD), a central delivery and receptor-binding domain (DRBD), and a CROPs domain (Fig. 1a) . Toxins bind to cell surface receptors via the DRBD and the CROPs and enter the cells via endocytosis [10] [11] [12] [13] [14] . Acidification in the endosome triggers conformational changes in the toxins that prompt the DRBD to form a pore and deliver the GTD and the CPD across the endosomal membrane [15] [16] [17] [18] . In the cytosol, the CPD is activated by eukaryote-specific inositol hexakisphosphate (InsP6) and subsequently undergoes autoproteolysis to release the GTD. The GTD then glucosylates small GTPases of the Rho family, including Rho, Rac, and Cdc42, and inhibits their functions [19] [20] [21] [22] [23] . Numerous structures have been reported for fragments of TcdA and TcdB, which have provided tremendous insight into the functions of these toxin domains 10, 12, 13, [24] [25] [26] [27] [28] . However, it remains unknown how individual domains interact within the supertertiary structure of the holotoxin and how the holotoxin dynamically responds in a precise stepwise manner to the environmental and cellular cues, such as low pH and InsP6, that lead to intoxication.
Here we report the crystal structure of TcdB holotoxin at 3.87-Å resolution, which was crystallized at an endosomal pH (pH 5.2) and displays an architecture that is distinct from that of the prior model derived from EM 29 . To probe the structural dynamics of TcdB in solution, we used a combination of small-angle X-ray scattering (SAXS), single-molecule fluorescence resonance energy transfer (smFRET), and cross-linking mass spectrometry (XL-MS). These experiments consistently demonstrated that the elongated CROPs of TcdB showed pH-dependent structural flexibility, which may help TcdB modulate its activity in response to environmental pH change. Furthermore, we reveal novel structural mechanisms underlying neutralization of TcdB by three antibodies. These findings collectively reveal new strategies for developing therapeutics and vaccines for treatment of CDI.
Results
Crystal structure of the full-length TcdB. Full-length TcdB holotoxin from the M68 strain of C. difficile was expressed using Bacillus megaterium 30 . Large-molecular-weight, multidomain proteins like TcdB are notoriously difficult to crystallize, and the structural flexibility of TcdB has also hampered 3D analysis by EM 29 . To facilitate crystal packing, we screened a panel of TcdB-binding VHHs, the antigen-binding region (V H ) of the heavy chain−only antibodies (also known as nanobodies or single-domain antibodies). The best X-ray diffraction data were collected at 3.87-Å resolution on a crystal of a heterotetrameric complex composed of TcdB and three neutralizing VHHs 18, 31 (5D, E3, and 7F). The TcdB-VHH complex was crystallized at pH 5.2, which is a physiologically relevant pH in an endosome (Fig. 1a,b and Table 1) .
We solved the crystal structure of the TcdB-VHH complex using molecular replacement (Methods). A complete structure of the TcdB holotoxin was built, except for two small regions (residues 944-949 and 1032-1047) that have no visible electron density because of high structural flexibility ( Fig. 1b and Supplementary  Fig. 1a-d) . We further validated this structure using an anomalous difference electron density map generated from a crystal of the TcdB-VHH complex soaked in tantalum bromide ( Supplementary  Fig. 1e ). E3 and 7F both bind to the GTD, whereas 5D binds to the DRBD ( Supplementary Fig. 1f ). This finding was further confirmed by three crystal structures of GTD-E3, GTD VPI10463 -7F, and TcdB -5D complexes, which we determined at 2.39-Å, 2.20-Å, and 2.97-Å resolution, respectively ( Table 1) .
The crystal structure reveals that TcdB is composed of three major components. The GTD and the CPD form the center piece, involving extensive interdomain interactions. The DRBD forms an extended module, interacting with both the GTD and the CPD on one side and pointing away from them. The most prominent finding is the elongated CROPs domain, which emerges from the junction of the CPD and the DRBD and stretches ~130 Å in the opposite direction, to curve around the GTD like a hook (Fig. 1b) . The overall architecture of TcdB at endosomal pH is distinct from structural models of TcdB and TcdA derived from a negative-stain EM study at neutral pH, in which the CROPs domain lies parallel to and interacts with the DRBD 29 ( Supplementary  Fig. 1g ). Furthermore, we observed that a portion of the poreforming region in the DRBD (residues 957-1129) adopts a conformation that is different from that of TcdA at neutral pH 24 . This conformation likely represents a rarely seen intermediate state of TcdB in response to endosomal pH that is 'frozen' by a neutralizing antibody (5D; discussed further below).
The unique structure of the CROPs domain. The CROPs domain of TcdB is composed of two types of repetitive sequences including twenty short repeats (SRs) of 20-23 residues and four long repeats (LRs) of 30 residues ( Fig. 2a and Supplementary Fig. 2a ). Each SR consists of a β-hairpin followed by a flexible loop, and each LR has three β-strands that form a twisted anti-parallel β-sheet with the β-hairpin of the preceding SR. Neighboring SRs are packed together into a ~3 1 screw axis with ~120° rotation between SRs, which creates a left-handed β-solenoid superhelix 32, 33 . The curvature of the CROPs arises because the straight, rod-like segments of the β-solenoid composed of SRs are interrupted by the interspersed LRs, which cause a ∼132-146° kink (Fig. 2b,c) . Structurally, the CROPs could be divided into four equivalent units, and superposition of CROPs I-IV yielded a Cα r.m.s. deviation of ~0.9-2.6 Å (Fig. 2c) .
Interestingly, we identified an unrecognized SR module (residues 1815-1834) at the C terminus of the DRBD. This new SR together with an upstream long loop and a short α-helix form a structurally distinct module (residues 1792-1834), which we refer to as the 'hinge' , because it connects the DRBD to the elongated CROPs. Furthermore, the hinge directly interacts with a three-stranded β-sheet in the CPD (residues 742-765, termed the β-flap) that is crucial for CPD activation 27 , as well as a three-helix bundle (residues 766-841, referred to as 3-HB) that is located in a crevice surrounded by GTD, CPD, DRBD, and CROPs (Fig. 2d,e and Supplementary  Fig. 2c ). Because of its strategic location, this hinge is primed to mediate structural communications among all four domains of TcdB. A functional role for this hinge is supported by our earlier studies showing that deletions in this area drastically reduce the toxicity of TcdB 34 . Additionally, hypervariable sequences near the hinge may contribute to differences in toxicity and antigenicity in TcdB variants produced by the hypervirulent C. difficile 027 ribotype and other less virulent strains [35] [36] [37] ( Supplementary Fig. 2b ).
Differences in the conformation of TcdB at neutral and acidic pH. To examine the solution structure of TcdB holotoxin, we carried out online size-exclusion chromatography coupled to SAXS (SEC-SAXS) for TcdB at pH 5.0 and pH 7.4 (Supplementary Table 1 and Supplementary Fig. 3a-c) . Curve-fit analysis showed that the calculated scattering profile from our crystal structure is well fit to the experimental scattering profile at pH 5.0 (Fig. 3a) , suggesting that the structure of TcdB in solution is similar to the crystal structure at pH 5.0. However, the calculated profile for the crystal structure disagrees with the experimental SAXS data at pH 7.4, particularly at the middle-angle (middle q) region of the scattering profile ( Fig. 3a) , which suggests that TcdB samples different conformations at neutral pH 38 . Guinier and P(r) analyses showed similar R g values at pH 5.0 and pH 7.4. However, D max at pH 5.0 (~233.0 Å) was longer than that at pH 7.4 (~205.0 Å). The D max at pH 5.0 was comparable to the value predicted from our crystal structure (~247 Å). The shorter D max at pH 7.4 was comparable to the value predicted for the TcdB core composed of the GTD, CPD, and DRBD (~203 Å) ( Supplementary Fig. 3d-e) , suggesting that the elongated CROPs may swing toward the TcdB core at neutral pH, which would shorten the maximum dimension.
To better characterize the conformation of the CROPs at pH 7.4, we employed XL-MS to determine interdomain interactions of TcdB using the MS-cleavable cross-linker disuccinimidyl sulfoxide (DSSO) 39 . Lysine residues on the surface of TcdB that can approach within a 30-Å Cα-Cα distance are preferentially cross-linked and identified via multistage tandem MS 39, 40 ( Supplementary Fig. 4a-c ). We identified a total of 87 intramolecular cross-links in TcdB at pH 7.4, representing 27 interdomain and 60 intradomain interactions (Fig. 3b , Supplementary Note 1, and Supplementary Data 1). When the XL-MS data were mapped to our crystal structure, almost all of these cross-links satisfied the distance cutoff of 30 Å, indicating a good correlation with the crystal structure of TcdB ( Supplementary Fig. 4d ).
Interestingly, we identified seven pairs of cross-linked peptides between the CROPs and the DRBD. Based on our crystal structure, the Cα-Cα distances between these cross-linked lysine residues range between 90 Å and 210 Å (Supplementary Fig. 4d ). This finding suggests that the CROPs of TcdB, especially the central portion of the CROPs around residues K1965 and K1977 and the C-terminal tip of the CROPs around residues K2234 and K2249, were able to move within ~30 Å of the DRBD (Fig. 3c) . Closing of the CROPs is consistent with the shorter D max of TcdB derived from SAXS at pH 7.4 and is similar to the closed conformation of TcdB and TcdA observed in the EM study 29 ( Supplementary Fig. 1g ). Because XL-MS captures dynamic and transient contacts in addition to stable structures, the time that the CROPs spends in a closed conformation at neutral pH remains unknown.
pH-dependent structural flexibility of the CROPs. We used smFRET to further probe the conformation of the CROPs 41 . We used three VHHs (7F, B39, and 5D) as molecular tools to label and capture TcdB in order to not modify its endogenous cysteine residues. Specifically, we attached the acceptor dye (Alexa Fluor 647) to 7F, which labels the core of TcdB holotoxin, and attached the donor dye (Alexa Fluor 555) to B39, which specifically binds to the CROPs IV 25 . Biotin-labeled 5D was used for immuno-pulldown of TcdB onto a microscope slide, which has no effect on TcdB conformational change, based on an ensemble FRET study ( Supplementary Fig. 4e ). In the structure of TcdB holotoxin at endosomal pH, the distance between dyes was ~47 Å, which would give a FRET efficiency near 0.5. Any movement of the CROPs would affect energy transfer between these two dye-labeled VHHs (Fig. 3d) . A structural model suggested that we would expect no FRET if TcdB holotoxin stably adopts a closed conformation.
For FRET analysis, we only selected complexes containing a single donor and acceptor dye that both photobleached to background during observation 42 ( Supplementary Fig. 4f and Supplementary Table 2 ). We observed single FRET peaks for the heterotetrameric TcdB-VHH complexes at both acidic and neutral pH ( Fig. 3e and Supplementary Fig. 4g ). A simple calculation from the mean FRET efficiency at pH 5.0 (0.532 ± 0.015) gave an estimated distance of 49.9 ± 0.05 Å between the dye-labeled VHHs, which is consistent with the crystal structure of TcdB holotoxin at acidic pH (~47 Å). Similar results were observed at pH 5.5 and pH 5.25 ( Supplementary Fig. 4h) .
At neutral pH, we observed a slight decrease in mean FRET efficiency (0.484 ± 0.007) and a 25% decrease in the distribution width at pH 7.0 (0.113 ± 0.002) relative to pH 5.0 (0.141 ± 0.026) (Fig. 3e) . Simple calculation based on FRET suggested a slight distance increase to 51.5 ± 0.05 Å at neutral pH, accompanied by a dramatic increase in the rate of conformational dynamics. We note that a single FRET pair is insufficient to position the CROPs relative to the rest of TcdB, and changes in conformational dynamics could affect the simple conversion of FRET to distance. However, these smFRET data suggest that the CROPs did not stably occupy a closed conformation at neutral pH under the conditions tested.
Thus far, we have identified two limiting structural states for TcdB: an open conformation revealed by the crystal structure at acidic pH and a closed conformation captured by XL-MS at neutral pH (Fig. 3d) . Combined with our SAXS and smFRET studies, these data collectively suggest that the CROPs predominantly occupies the open state at acidic pH but dynamically samples an ensemble of conformations relative to the core of TcdB at neutral pH. Such protein dynamics are faster than our 100-ms integration time in smFRET, so motions between open and closed conformations would be time-averaged into a single peak 43 . The lack of stabilizing contacts between the CROPs and the TcdB core and the potential structural rearrangement in the hinge that connects the DRBD and the CROPs should permit such conformational sampling.
A pore-forming intermediate state of TcdB at endosomal pH. The DRBD serves to protect the hydrophobic pore-forming region (residues 957-1129), which is predicted to be released upon endosome acidification in order to form a pore that delivers the GTD and the CPD to the cytosol. The pore-forming activity of TcdB also contributes to cell necrosis observed in vitro 16, 44 . A structural comparison between TcdB holotoxin at acidic pH and a TcdA fragment at neutral pH revealed drastic differences in the homologous C-terminal portion of the pore-forming region (residues 1032-1093 in TcdB) ( Fig. 4a,b) . In TcdA, this region adopts a mixed α/β configuration, in which hydrophobic residues are shielded in a continuous groove formed mostly by β-sheets in the DRBD (Fig. 4c,d ). However, in the acidic conformation of TcdB, no electron density was visible for residues 1032-1047, likely because of high flexibility, indicating that these residues unfolded and detached from the toxin core at endosomal pH. Furthermore, TcdB residues equivalent to the α2 in TcdA unfolded into a loop, whereas TcdB residues equivalent to the β3 and part of the α3 in TcdA assembled into a new helix that occupied the same area as the original α3 in TcdA. Because of this transition, hydrophobic residues in TcdB (residues 1084-1093), which are equivalent to the C-terminal portion of the α3 helix in TcdA, bulged out as an extended loop. Intriguingly, the conformational change did not spread into the region where TcdB is bound by 5D (residues 1094-1134), which maintains a similar conformation to that observed in TcdA.
We produced TcdB 1072-1433 to further examine the effect of acidic pH and 5D on the pore-forming region. Using an environmentally sensitive fluorescent dye 16, 35, 45 , we observed an increase in exposed hydrophobic surface in TcdB 1072-1433 upon acidification, which was inhibited by 5D ( Supplementary Fig. 5a ,b). This is consistent with a pH-triggered conformational change in TcdB that is blocked by 5D. We then determined the crystal structure of TcdB 1072-1433 in complex with 5D at pH 8.5 (Table 1) , which revealed that its poreforming region adopts a TcdA-like conformation at neutral pH (Supplementary Fig. 5c-d ). Together, these findings suggest that the novel conformation observed in the pore-forming region of TcdB likely represents an intermediate state induced by endosomal pH.
Furthermore, we found that the binding mode of 5D to TcdB is almost identical at neutral and acidic pH, in which 5D directly binds P1105, L1107, N1110, and L1112 in the pore-forming region ( Supplementary Fig. 5e -f and Supplementary Table 3 ). Prior mutagenesis studies have shown that the pore-forming region around the 5D-binding site in TcdB is crucial for pore formation and cellular toxicity. For example, mutation of L1107 (L1107K), which is located in the β4 and targeted by 5D, caused a >1,000-fold decrease in toxicity 16, 24 . These findings thus suggest that 5D is able to bind to TcdB at both neutral and acidic pH and fix the conformation of β4-β5 in TcdB, inhibiting the conformational changes necessary for pore formation at endosomal pH. This notion is further supported by observations that TcdB-induced calcein release from liposomes at pH 4.6 was significantly reduced by 5D and that 5D prevented TcdB from dissipating the valinomycin-induced membrane potential in liposomes (Fig. 4e,f) .
Taken together, these findings suggest that 5D neutralizes TcdB 31, 46 by preventing the pore-forming region from completing the necessary pH-induced conformational change. Notably, the pore-forming region recognized by 5D is highly conserved among a family of large clostridial glucosylating toxins (LCGTs), which include TcdA and TcdB, Clostridium novyi α-toxin, Clostridium sordellii lethal and hemorrhagic toxins, and Clostridium perfringens toxin 47 (Fig. 4c) . Therefore, this portion of the pore-forming region represents a good target for the development of broad-spectrum vaccines and antibodies targeting TcdA, TcdB, and other LCGTs.
Modulation of autoprocessing of TcdB. Activation of the CPD by InsP6 upon cell entry is a critical step in regulating the pathology of TcdA and TcdB 27, 48 . The structures of the apo CPD in TcdB holotoxin and an InsP6-bound CPD fragment are similar, except for the β-flap 11, 27, 49 (Fig. 5a,b) . In the CPD fragment, InsP6 triggers a ~90° rotation of the β-flap (Fig. 5b) , which activates the CPD by properly ordering the active site and the substrate pocket 27, 49 . However, the β-flap partially occupies the P1 substrate pocket of the CPD in the TcdB holotoxin, which would prevent substrate binding 50 . Furthermore, the InsP6-triggered rotation of the β-flap is prohibited in TcdB holotoxin, because it would otherwise sterically clash with the neighboring 3-HB (Fig. 5c,d) .
Interestingly, we observed a zinc atom in the CPD that simultaneously interacts with the catalytic dyad (H654 and C699), the β-flap (H758), and a residue (D547) near the scissile bond (L544-G545) in the GTD ( Supplementary Fig. 6a-c) . A similar zinc was observed in TcdA 24 but never seen in any structures of a CPD fragment. As a result, the β-flap in TcdB holotoxin helps to protect the catalytic C699 through a Zn-H758 interaction, and the Zn-D547 interaction also prevents the scissile bond from entering the active site. These findings thus provide new insight into how TcdB autoprocessing is inhibited in the holotoxin.
Aside from allosteric modulation by InsP6, some studies have suggested that the CROPs also affects TcdB autoprocessing 24, 51, 52 . We found that the InsP6-induced cleavage of the GTD was much more efficient in TcdB , which does not have the hinge or the CROPs, than in the holotoxin, suggesting that the CROPs and the hinge help inhibit the CPD function in TcdB holotoxin ( Supplementary Fig. 6d ). Furthermore, a previous study showed that TcdA , which carries the hinge, showed a weaker InsP6-dependent cleavage of GTD than TcdA 1-1795 without the hinge 24 . These data suggest that the hinge is involved in regulation of TcdB and TcdA autoprocessing. Notably, the hinge interacts with the β-flap and the 3-HB in TcdB holotoxin, and they together form the 'heart' of TcdB that connects all four domains (Fig. 5c,d ). Because the β-flap and the 3-HB are important for coupling between InsP6 binding and CPD activation, structural rearrangement in the hinge, associated with pH-dependent movement of the CROPs, could contribute to the regulation of CPD function.
VHH 7F and E3 reveal two distinct neutralizing epitopes on the GTD. 7F inhibits GTD cleavage 18 but does not directly interact with the CPD. Instead, 7F binds to the C terminus of the GTD, immediately juxtaposed to the cleavage site ( Supplementary Fig. 5g-i) . Notably, the CDR3 of 7F binds to an α-helix upstream of the scissile bond and a neighboring α-helix with extensive polar and hydrophobic interactions (Supplementary Table 3 ). Such interactions interfere with the movement of the scissile bond into the CPD cleavage site and a proper orientation of GTD relative to CPD and thus inhibit GTD cleavage (Supplementary Fig. 6d ).
E3 inhibits Rho glucosylation by targeting the GTD 18, 31 . In two independently solved crystal structures using the GTD fragment or TcdB holotoxin, E3 binds to the N-terminal four-helix bundle (residues 1-90) in a similar manner, involving extensive polar and hydrophobic interactions ( Supplementary Fig. 5j and Supplementary Table 3 ). Because the structure of a GTD-Rho complex has not been reported, it remains unknown how E3 may affect GTD-Rho interactions or GTD catalysis. The homologous four-helix bundle is also found in other LCGTs, which is believed to be involved in plasma membrane binding of the glucosyltransferase domain 11, [53] [54] [55] . It suggests that E3 may interfere with membrane association of the GTD. The structure of the GTD-E3 complex thus lays the foundation for further validation and use of this mechanism as a new strategy to counteract TcdB and potentially other LCGTs.
Discussion
Prior studies of CDI have provided key insights into the activity and pathogenesis of TcdA and TcdB, and numerous structures have been determined for fragments of these toxins 11 . However, knowledge of the holotoxin structures is central to bridge the structure−function gap. Our comprehensive analyses of the structure of TcdB holotoxin collectively demonstrate that TcdB has evolved a delicate mechanism to coordinate its four structurally and functionally distinct domains in order to balance the needs for self-protection and timely activation. Notably, the β-flap, the 3-HB, and the hinge are colocalized at the 'heart' of TcdB holotoxin, which are well positioned to modulate structural communications among all four domains and coordinate their activities (Fig. 5c,d and Supplementary Fig. 6b,c) . Interestingly, TpeL is the only LCGT member that does not possess a CROPs domain or a hinge-like region 56 . Furthermore, TpeL has 13 amino acids deleted near the C terminus of the 3-HB compared with other LCGTs, which suggests that TpeL may have a different structure in this modulatory area. The structure of TcdB holotoxin thus provides a blueprint to guide future studies on how TcdB and other LCGTs respond to environmental and cellular cues during intoxication. Such mechanistic understanding could help in developing new therapeutics that promote extracellular activation of the CPD and premature cleavage of the GTD before cell entry 57 . K303  K784  K303  K787  K380  K784  K380  K787  K506  K784  K506  K787  K529  K572  K536  K765   K11  K904  K7  K904  K70  K857  NT  K916   K572  K1760  K646  K1775  K646  K846  K784  K1773  K784  K846  K787  K846  K791  K1773  K791  K846   K1117  K2249  K1120  K2234  K1120  K2249  K1126  K2249  K1504  K1977  K1549  K1965  K1549  K1977 Linkages identified by XL-MS The conformational dynamics of the CROPs may impact receptor binding of TcdB and therapy. Chondroitin sulfate proteoglycan 4 (CSPG4) is a TcdB receptor that is believed to interact with the DRBD, the hinge, and the CROPs 14, 58 (Supplementary Fig. 7a ). Notably, two residues essential for CSPG4 binding (Y1824 and N1839) are located in the hinge and the first SR of the CROPs 58 . Therefore, conformational flexibility of the CROPs and the hinge may affect the engagement of CSPG4 or the release of CSPG4 as TcdB interacts with multiple host receptors during different stages of cell entry 13, 14, 58 . In contrast, Frizzled proteins (FZDs), which are the major TcdB receptors in the colonic epithelium 59 , bound to TcdB holotoxin similarly at pH 5 and pH 7.5, based on an in vitro pulldown assay, and were not affected by conformational dynamics of the CROPs (Supplementary Fig. 7b ). FZD binds TcdB in a middle portion of the DRBD, and its binding site is adjacent to, but separate from, the pore-forming region 13 ( Supplementary  Fig. 7c ). Thus, FZD binding helps orient the pore-forming region of TcdB near the membrane. Interestingly, bezlotoxumab, which is believed to affect TcdB binding to host cells, binds TcdB in the CROPs I and II 28, 58 . However, in the context of TcdB holotoxin at endosomal pH, there is insufficient space near the CROPs I to allow binding, due to steric clashes with the GTD and the DRBD ( Supplementary Fig. 7d,e) . Therefore, bezlotoxumab may interfere with the conformational change in the CROPs, and the therapeutic relevance of this novel feature of bezlotoxumab is well worth further studies.
Aside from unveiling structural weakness in TcdB holotoxin, our studies reveal distinct mechanisms for antibody neutralization of TcdB by inhibiting autoprocessing and activation of the toxin, glucosylation of Rho GTPases, or transmembrane delivery of the toxin. These findings provide the structural basis for antibody engineering to improve their antitoxin activities or developing multidomain antibodies that simultaneously target multiple neutralizing epitopes on the toxins 31, 46, 60 . Taken together, our studies expose crucial structural and functional vulnerabilities of TcdB that provide novel avenues for the development of next-generation vaccines and therapeutics that have enhanced potency and broad reactivity across different C. difficile strains.
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Methods
No statistical method was used to predetermine sample size. The experiments were not randomized and were not performed with blinding to the conditions of the experiments.
Cloning, expression, and purification of recombinant proteins. TcdB produced by the M68 strain of C. difficile was used throughout this study. TcdB holotoxin and its GTD (residues 1-543) were expressed as described previously 30 . The gene encoding the four VHHs (5D, E3, 7F, and B39) and the GTD of TcdB produced by the VPI 10463 strain (residues 1-542, termed GTD
VPI10463
) and a truncated DRBD of TcdB (residues 1072-1433, TcdB ) were cloned into a modified pET28a vector that had a 6×His/SUMO (Saccharomyces cerevisiae Smt3p) tag introduced into the N terminus of all proteins. A TcdB fragment (residues 1-1805, TcdB ) was cloned into a modified pET22b vector that had a twin-Strep tag introduced between the SUMO tag and TcdB 1-1805 and a C-terminal 6×His tag. All mutants were generated via two-step PCR and verified using DNA sequencing.
5D, E3, 7F, B39, GTD
, TcdB , and TcdB 1072-1433 were expressed in Escherichia coli strain BL21-Star (DE3) (Invitrogen). Bacteria were cultured at 37 °C in LB medium containing kanamycin or ampicillin. The temperature was reduced to 16 °C when OD 600 reached ~0.8. Expression was induced with 1 mM IPTG (isopropyl-b-d-thiogalactopyranoside) and continued at 16 °C overnight. The cells were harvested via centrifugation and stored at −80 °C until use.
The His 6 -tagged TcdB, GTD, and the His 6 -SUMO-tagged 5D, E3, 7F, B39, GTD VPI10463 , TcdB , and TcdB 1072-1433 were purified using Ni
2+
-NTA (nitrilotriacetic acid, Qiagen) affinity resins in a buffer containing 50 mM Tris, pH 8.5, 400 mM NaCl, and 10 mM imidazole. The proteins were eluted with a high-imidazole buffer (50 mM Tris, pH 8.5, 400 mM NaCl, and 300 mM imidazole) and then dialyzed at 4 °C against a buffer containing 20 mM Tris, pH 8.5, 1 mM TCEP, and 40 mM NaCl. The 6×His-SUMO tag of 5D, E3, 7F, B39, GTD
VPI10463
, and TcdB 1072-1433 were cleaved by SUMO protease. These proteins, as well as the TcdB holotoxin and GTD with an uncleaved His-tag, were further purified by MonoQ ion-exchange chromatography (GE Healthcare) in a buffer containing 20 mM Tris, pH 8.5, and eluted with a NaCl gradient. TcdB , after cleavage by SUMO protease, was further purified using streptavidin resins.
The TcdB-5D-E3-7F complex was assembled by mixing purified TcdB holotoxin with the three purified VHHs at a molar ratio of 1:2:2:2 for 2 h on ice. The complex was then purified via MonoQ ion-exchange chromatography in 20 mM Tris, pH 8.5, then by a Superose 6 size-exclusion chromatography (SEC; GE Healthcare) in 20 mM Tris, pH 8.5, 1 mM TCEP, and 40 mM NaCl. The GTD-E3, GTD VPI10463 -7F, and TcdB 1072-1433 -5D complexes were made by mixing the purified GTD, GTD
, and TcdB 1072-1433 with E3, 7F, and 5D at a molar ratio of 1:2, respectively, for 2 h on ice, then further purified using a MonoQ ion-exchange column (20 mM Tris, pH 8.5) and a Superdex-200 Increase SEC (20 mM Tris, pH 8.5, 1 mM TCEP, and 40 mM NaCl). All protein complexes were concentrated to ~10 mg/ml and stored at −80 °C until use.
Crystallization. Initial crystallization screens for all four protein complexes were carried out at 20 °C with a Gryphon crystallization robot (Art Robbins Instruments) using high-throughput crystallization screening kits (Hampton Research and Qiagen). Extensive manual optimizations were then performed at 20 °C using the hanging-drop vapor-diffusion method when proteins were mixed with reservoir solution at a 1:1 ratio.
(1) The best crystals for the TcdB-5D-E3-7F complex suitable for X-ray diffraction were obtained in a reservoir containing 0.1 M sodium acetate, 0.1 M magnesium acetate, and 5% PEG 8 K (final pH 5.2) with a protein concentration of ~4 mg/ml. The crystals were cryoprotected in the mother liquor supplemented with 25% (v/v) ethylene glycol. The tantalum bromide cluster-derivatized crystals were obtained by adding a trace amount of tantalum bromide powder to the crystallization drop. The TcdB-5D-E3-7F crystals were soaked in this solution for 1-3 d until the crystals turned green, and they were then cryoprotected similarly as the native crystals.
(2) The best crystals for the GTD-E3 complex were obtained in a reservoir containing 0.2 M potassium acetate and 20% PEG 3350 with a protein concentration of ~10 mg/ml, which were then cryoprotected in the same mother liquor supplemented with 25% (v/v) glycerol. -5D complex were obtained in a reservoir containing 0.1 M Tris, pH 8.5, 0.2 M lithium sulfate, 18% PEG 4000 with a protein concentration of ~5 mg/ml and were cryoprotected in the same mother liquid.
Data collection and structure determination. The X-ray diffraction data for the GTD-E3 complex were collected at 100 K at beam line BL9-2 at Stanford Synchrotron Radiation Lightsource (SSRL). All other data were collected at 100 K at the NE-CAT beamline 24-ID-C, Advanced Photon Source (APS). The data were processed with HKL2000 package 61 or XDS as implemented in RAPD (https:// github.com/RAPD/RAPD) 62 .
In order to determine the structure of the TcdB-5D-E3-7F complex, we first determined the structures of the GTD-E3 and GTD VPI10463 -7F complexes using molecular replacement under PHENIX.Phaser 63 . We used structures of the GTD (PDB 2BVL) 26 and the homology models of E3 or 7F that were built based on a VHH in PDB 3V0A as search models 26, 64 . The structure of the TcdB-5D-E3-7F complex was solved by three rounds of molecular replacement with PHENIX. Phaser. We first located the three VHHs and the N-terminal fragment of TcdB (residues 1-1805) using the structures of a truncated TcdA (residues 1-550 and 743-1285; PDB 4R04), the CPD of TcdB (residues 551-742; PDB 3PEE), the DRBD of TcdB (residues 1285-1804; PDB 6C0B), the structures of the GTD-E3 and the GTD VPI10463 -7F complexes determined in our lab, and a homology model for 5D (PDB 3V0A) as models 13, 24, 27, 64 . This partial structure was defined as a fixed partial model for a second round of molecular replacement using the CROPs I and II of TcdB (residues 1834-2100; PDB 4NP4) and the CROPs IV of TcdB (residues 2249-2366; PDB 4NC2) as search models 25, 28 . After the structures of CROPs I, II, and IV were found, the position of CROPs III was located by another round of molecular replacement using CROPs I of TcdB (residues 1835-1968; PDB 4NP4) as a search model. Structural modeling and refinement were carried out iteratively using COOT 65 , Prosmart external restraints under Refmac5 66 , then Phenix-Rosetta 67 and Phenix.Refinement 63 with enforcement of secondary structure restraints. Along this process, the electron density for residues in the hinge region improved steadily, which eventually allowed manual model building in this region. Final refinement was performed with jelly body refinement and Refmac5 (ref. 66 ). The model of the TcdB holotoxin was additionally validated using anomalous signal from tantalum bromide cluster-derivatized crystals.
The crystals of the TcdB
1072-1433
-5D complex showed anisotropic diffraction. The diffraction data were scaled using diffraction anisotropy server (https:// services.mbi.ucla.edu/anisoscale/), which yielded an ellipsoidal resolution boundary with limits of 3.2, 3.2, and 3.0 Å along the a*, b*, and c* axes, respectively 68 . The structure of the TcdB 1072-1433 -5D complex was solved via molecular replacement with PHENIX.Phaser using a fragment of the TcdB holotoxin (residues 1098-1431) as a search model. All the refinement progress was monitored with the free R value using a 5% randomly selected test set 69 . The structures were validated using MolProbity 70 . The TcdB-5D-E3-7F complex has 85.91%, 13.34%, and 0.75% residues in Ramachandran-favored, allowed, and outlier regions, respectively. All of the other three structures have good geometry with no Ramachandran outliers observed. Data collection and structural refinement statistics are listed in Table 1 . All structure figures were prepared using PyMOL (DeLano Scientific).
SAXS. SEC-SAXS experiments were performed at SSRL beamline 4-2 as described previously4 45 (Supplementary Table 1 ). TcdB holotoxin was exchanged into a buffer containing PBS, pH 7.4, and 5 mM DTT, or 20 mM sodium acetate, pH 5.0, 50 mM NaCl, and 5 mM DTT, and then concentrated to 20 mg/ml. SEC-SAXS data were collected at pH 5.0 and pH 7.4 using Superdex-200 Increase PC 3.2/300 columns (GE Healthcare). A total of 500 images were recorded with 1 s exposure every 5 s at a 0.05 ml/min flow rate. After background (buffer) data collection, the X-ray shutter was closed until the main elution peak showed up, in order to keep the sample cell clean from accumulation of dirt. Data reduction and initial analysis were performed using SECPipe, a real-time data processing and initial analysis pipeline at SSRL beamline 4-2. SECPipe implements the program SASTOOL (https://www-ssrl.slac.stanford.edu/smb-saxs/content/documentation/sastool) and ATSAS AUTORG 71 . The first 100 images were used for background images. The data were presented as I(q) versus q, where q = 4πsin(θ)/λ, 2θ is the scattering angle, and λ is the wavelength of the X-ray. After careful manual inspection, the average profiles were generated and used for further analysis (image number 290-304 for pH 5.0 and 280-289 for pH 7.4). The program GNOM was used for the indirect Fourier transform to estimate the distance distribution function P(r) 72 . The theoretical scattering profile of the crystal structure was computed and fitted with experimental data using the program CRYSOL 73 .
DSSO cross-linking of TcdB. TcdB holotoxin (50 μl, 10 μM) in PBS (pH 7.4) was reacted with DSSO at the molar ratio of 1:100 for 1 h at room temperature. Crosslinking was quenched by addition of 50-fold excess ammonium bicarbonate for 10 min, and the resulting products were subjected to enzymatic digestion using a FASP protocol. Briefly, cross-linked proteins were transferred into Millipore Microcon Ultracel PL-30 (30-kDa filters), reduced/alkylated, and digested with Lys-C/trypsin sequentially 39 . The resulting digests were desalted and fractionated by peptide SEC 74 . The fractions containing cross-linked peptides were collected for subsequent MS n analysis 39 . Three biological replicates were performed to obtain highly reproducible cross-link data. To confirm intra-TcdB interactions, DSSO cross-linked TcdB was separated via 1D SDS-PAGE, and the cross-linked TcdB monomer band was selected for in-gel digestion 75 . The extracted tryptic digest was fractionated by SEC and analyzed by LC MS n .
LC MS n analysis. LC MS n analysis was performed using a Thermo Scientific Dionex UltiMate 3000 system online coupled with an Orbitrap Fusion Lumos mass spectrometer. A 50 cm × 75 μm Acclaim PepMap C18 column was used to separate peptides over a gradient of 1% to 25% ACN in 82 min at a flow rate of 300 nl/min. Two different types of acquisition methods were utilized to maximize the identification of DSSO cross-linked peptides: (1) top four data-dependent MS 3 and (2) targeted MS 3 acquisition optimized for capturing DSSO cross-linked peptides by utilizing the mass difference between characteristic MS 2 fragment ions of DSSO cross-linked peptides (α − β) (that Δ = α T − α A = β T − β A = 31.9721 Da) 76 .
Data analysis and identification of DSSO cross-linked peptides. MS
n data extraction and analysis were performed as previously described 76 . MS 3 data were subjected to Protein Prospector (v.5.19.1) for database searching, using BatchTag against a custom database containing nine protein entries concatenated with its random version. The mass tolerances were set as ±20 p.p.m. and 0.6 Da for parent and fragment ions, respectively. Trypsin was set as the enzyme with three maximum missed cleavages allowed. Variable modifications included protein N-terminal acetylation, cysteine carbamidomethylation, methionine oxidation, and N-terminal conversion of glutamine to pyroglutamic acid. Additionally, three defined modifications on uncleaved lysines were chosen, which included alkene (C 3 H 2 O; +54 Da), sulfenic acid (C 3 H 4 O 2 S; +104 Da), and thiol (C 3 H 2 SO; +86 Da), representing cross-linker fragment moieties on lysine residues. Only a maximum of four modifications on a given peptide was allowed during the search. Initial acceptance criteria for peptide identification at the MS 3 level required a reported expectation value of ≤0.2, which yielded a false discovery rate of >0.5%. The inhouse program Xl-tools was used to identify, validate, and summarize cross-linked peptides based on MS n data and database searching results
76
. Following integration of MS n data, no cross-links involving decoy proteins were identified. Only crosslinked peptides that were identified in all three biological replicates are reported.
Single-molecule FRET analysis of TcdB. A cysteine residue was introduced by mutagenesis into the N terminus of 7F (at the −1 position) or into a surfaceexposed loop in B39 (G42C). Expression and purification of the mutant VHHs were similar to those of the wild-type proteins, except 5 mM DTT was used in all the buffers during purification. 7F was labeled with Alexa-647 maleimide, whereas B39 was labeled with Alexa-555 maleimide (Thermo Fisher Scientific). The labeling efficiency was determined by UV-Vis spectroscopy to be >90%. 5D was biotinylated using EZ-Link NHS-PEG4-Biotin (Thermo Fisher Scientific) at pH 6.5 to preferentially label the N-terminal amine. TcdB holotoxin in complex with the Alexa-647-labeled 7F, the Alexa-555-labeled B39, and the biotin-labeled 5D was further purified using a Superose 6 SEC to remove the excess VHHs.
Cleaned quartz slides were passivated with biotinylated bovine serum albumin, then with a mixture of 2% Biolipidure 203 and 0.2% Biolipidure 206 (NOF America Corp.), before streptavidin was added. After this treatment, the preformed TcdB-VHH complex showed no nonspecific binding to the slide at concentrations orders of magnitude higher than the 100 pM concentration used to achieve optical resolution between single molecules. Samples were incubated for 5 min, rinsed briefly, and exchanged into the indicated buffer supplanted with 0.1% glucose, 20 U/ml pyranose oxidase, 1,000 U/ml catalase and 0.0001% (v/v) cyclooctatetraene to prevent photobleaching and blinking. Using pyranose oxidase and catalase insures pH stability at any arbitrary pH 77 . Measurements were made in 50 mM HEPES, pH 7, 100 mM NaCl or 50 mM acetate, pH 5, and 100 mM NaCl. For intermediate pH, a mixture of citrate and phosphate was used at 50 mM with 100 mM NaCl.
At such low protein concentrations, the non-covalently bound VHHs partially dissociated, so measurements had to be made rapidly, which required seven repeated surface preparations at each pH condition. Samples were imaged using a prism-based Total Internal Reflection Fluorescence microscope constructed on an IX71 base with a 60×/1.2-NA water-immersion objective (Olympus) 42 . Alternating laser excitation with mechanical shutters (Uniblitz) was used to confirm the presence of both a donor and an acceptor dye in all molecules used for analysis. Samples were excited with a laser diode at 637 nm (Coherent Inc.) for Alexa-647 and a diode pumped solid-state laser at 532 nm (Laser Quantum USA) for Alexa-555. Emissions from donor and acceptor were separated using an Optosplit ratiometric image splitter (Cairn Research Ltd) containing a 645-nm dichroic mirror with a 585/70 band pass filter for the donor channel and a 670/30 band pass filter for the acceptor channel (IDEX Health & Science). The replicate images were relayed to a single iXon DU-897 EMCCD camera (Andor Technologies) at a frame rate of 10 Hz.
Data were processed in home-written MATLAB scripts to cross-correlate the replicate images and extract time traces for diffraction limited spots with intensity above baseline. We selected only complexes containing a single donor and acceptor dye that showed anti-correlated photobleaching to baseline in a single time step. From the magnitude of the anti-correlated photobleaching event, we could perform per-molecule γ-normalization, which allowed us to report the absolute FRET efficiency 42 . The FRET efficiency was compiled into histograms, which were fit to Gaussian functions.
Photophysical controls for FRET assays. To insure that FRET changes were not the result of photophysical changes, we measured the relative quantum yield and fluorescence anisotropy for the free dyes, the dye-labeled VHHs, and the individual dye-labeled VHHs in complex with TcdB. All measurements were carried out at a dye concentration of 10 nM using the same buffers as the smFRET at pH 7 and pH 5.
Ensemble fluorescence was recorded on an ISS PC1 photon counting spectrofluorometer using a 2.0-mm excitation slit and a 2.0-mm emission slit. Alexa-555-and Alexa-647-labeled samples were excited at 532 nm and at 637 nm, respectively. Concentrations of samples used for fluorescence were determined from absorption measurements using the same cuvette. The emission intensity was taken as the sum of a 20-nm window about the emission maxima. Relative quantum yields were calculated by normalizing the intensities to the emission of free dye at pH 7. Anisotropy measurements were collected with a 2.0-mm excitation slit and a 2.0-mm emission slit using Glan Thompson polarizers in the L conformation. Emission was recorded at 567 nm and 670 nm for the donor and acceptor, respectively. All measurements were done in triplicate and reported as the mean and standard error (Supplementary Table 2 ).
The effect of 5D on the fluorescence emission of the TcdB-B39-7F complex was investigated by ensemble FRET study. TcdB (0.5 μM) was incubated with an equimolar ratio of the Alexa-555-labeled B39, the Alexa-647-labeled 7F, or both VHHs with or without 5D at room temperature for 15 min in a buffer containing 100 mM NaCl and either 50 mM HEPES, pH 7.0, or 50 mM sodium acetate, pH 5.0. Fluorescence was measured on a Spectramax M2e cuvette module with excitation at 540 nm, cutoff at 550 nm, and fluorescence emission at 550-730 nm. The experiments were performed in duplicate.
